These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3099800)

  • 1. HLA-DR antigens in gold-induced neutropenia.
    Aaron S; Davis P; Bertouch J
    Arthritis Rheum; 1986 Dec; 29(12):1515-7. PubMed ID: 3099800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H; Eiberg B; Helin P; Svejgaard A
    Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA and the response to gold therapy in rheumatoid arthritis.
    Carette S; Lang JY; Mathieu JP; Roy R; Morissette J
    Arthritis Rheum; 1987 Feb; 30(2):233. PubMed ID: 3103634
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold induced thrombocytopenia: 12 cases and a review of the literature.
    Adachi JD; Bensen WG; Kassam Y; Powers PJ; Bianchi FA; Cividino A; Kean WF; Rooney PJ; Craig GL; Buchanan WW
    Semin Arthritis Rheum; 1987 May; 16(4):287-93. PubMed ID: 3110956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia occurring during the course of chrysotherapy: a review of 25 cases.
    Aaron S; Davis P; Percy J
    J Rheumatol; 1985 Oct; 12(5):897-9. PubMed ID: 3936931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis.
    Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME
    Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA DR antigens and gold toxicity.
    Gran JT; Husby G; Thorsby E
    Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis and neutropenia secondary to gold thiomalate therapy for rheumatoid arthritis.
    Smith MD
    Aust N Z J Med; 1986 Feb; 16(1):72-4. PubMed ID: 3085648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and rheumatoid arthritis: an analysis of multicase families.
    Ollier W; Silman A; Gosnell N; Currey H; Awad J; Doyle P; McCloskey D; Alonso A; Hossain MA; Festenstein H
    Dis Markers; 1986 Jun; 4(1-2):85-98. PubMed ID: 3330700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR; Ström H; Bjelle A; Möller E
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA frequency and haplotype analysis in a family study of adult onset rheumatoid arthritis.
    Colaco CB; Awad J; Festenstein H; Fielder A; Batchelor JR; Alonso A; McCloskey D; Shipley M; Corbett M; Roitt IM
    Dis Markers; 1986 Jun; 4(1-2):99-102. PubMed ID: 3502563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA DR antigens and disease expression in rheumatoid arthritis.
    Griffin AJ; Wooley P; Panayi GS; Batchelor JR
    Ann Rheum Dis; 1984 Apr; 43(2):218-21. PubMed ID: 6424587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the HLA system in rheumatoid arthritis].
    Minev M; Martinova F; Sheĭtanov I; Andreev T; Dimitrova D
    Vutr Boles; 1987; 26(3):72-5. PubMed ID: 3617709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA studies in familial and sporadic rheumatoid arthritis.
    Khan MA; Khan MK
    Dis Markers; 1986 Jun; 4(1-2):67-76. PubMed ID: 3482988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.